EUCTR2012-000375-16-FR进行中（未招募）1 期
Effect of Liraglutide on fatty liver content evaluated by 1H-spectroscopy and lipoprotein kinetic, in patients with type 2 diabetes
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- CHU Dijon
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 60
排除标准
- 未提供
研究者
相似试验
终止
4 期
Effect of Liraglutide on Fatty Liver Content and Lipoprotein MetabolismType 2 DiabetesNCT02721888Centre Hospitalier Universitaire Dijon127
进行中（未招募）
1 期
The effect of semaglutide therapy on hepatic fat content and on the acute response of liver fat to high-fat loadMedDRA version: 20.0Level: PTClassification code: 10029883Term: Obesity Class: 100000004861ObesityCTIS2023-504988-16-00Institut Klinicke A Experimentalni Mediciny16
已完成
不适用
Effect of liraglutide on lipid profile in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000014097Yokohama City University Hospital30
Unknown
3 期
Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian AdultsNon-alcoholic Fatty Liver Disease (NAFLD)Weight LossNon-alcoholic Steatohepatitis (NASH)NCT02654665Changi General Hospital36
招募中
1 期
Effect of orlistat on LIVER fat content in obese subjects with NAFLD and High concEntrAtion of pLasma proneurotensin THrough inhibition of neurotensin secretion and actioon-Alcoholic Fatty Liver DiseaseMedDRA version: 20.0Level: LLTClassification code: 10031743Term: Other chronic nonalcoholic liver disease Class: 10019805CTIS2022-500366-10-00Region Skane60